Calithera Biosciences, Inc. (CALA) |
| 0.0004 0 (0%) 09-09 16:00 |
| Open: | 0.0003 |
| High: | 0.0004 |
| Low: | 0.0001 |
| Volume: | 315 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | Other OTC |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 0.001 |
| 52w Low: | 0.0001 |
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 24 Apr 2025
Methes Energies (MEIL) Stock Price, News & Analysis - Stock Titan
Fri, 05 Jul 2024
EFTR Stock Price and Chart — OTC:EFTR - TradingView
Sat, 04 Feb 2023
CALA Stock Price and Chart — OTC:CALA - TradingView
Tue, 10 Jan 2023
Biotech company Calithera plans its own death. Will others follow? - The Business Journals
Mon, 17 May 2021
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037) - PR Newswire
Thu, 11 Jul 2019
BNGI Stock Price and Chart — OTC:BNGI - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
